These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7063941)

  • 1. [Use of vasopressin in the asthenic syndrome of cerebral arteriosclerosis].
    Akimov GA; Medvedev VI; Stepovik NV; Bakharev VD; Kaurov OA
    Sov Med; 1982; (1):49-52. PubMed ID: 7063941
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy with Gerovital H3 in ambulatory conditions].
    Creţeanu C; Hurjui J; Bejan V; Duda R; Albu D
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(1):169-74. PubMed ID: 5552552
    [No Abstract]   [Full Text] [Related]  

  • 3. Double-blind trial of naftidrofuryl in the treatment of cerebral arteriosclerosis.
    Gerin J
    Br J Clin Pract; 1974 May; 28(5):177-8. PubMed ID: 4604345
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic experience with the use of piritinol (Encephabol) in geriatrics].
    Romano F
    Minerva Med; 1970 Jun; 61(51):2875-7. PubMed ID: 5432045
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cosaldon in the treatment of cerebral arteriosclerosis].
    Dzialek E; Orzechowska-Wolczyk M; Zawadzki Z
    Wiad Lek; 1975 Sep; 28(18):1547-9. PubMed ID: 1163042
    [No Abstract]   [Full Text] [Related]  

  • 6. [Wallerox increases cerebral circulation and heart capacity].
    Heynen U
    Z Allgemeinmed; 1971 Dec; 47(34):1823-5. PubMed ID: 5003212
    [No Abstract]   [Full Text] [Related]  

  • 7. [Psychotropic effects of a cerebral blood circulation stimulating agent in geriatric patients].
    Scholing WE; Kleiter G; Krysl LR; Riedl J
    Med Klin; 1972 Mar; 67(9):298-303. PubMed ID: 4558188
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experience with the use of pangamic acid (vitamin B-15) in arteriosclerosis of the vessels of the brain with mental disorders].
    Rastopchin IP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(2):264-7. PubMed ID: 5439840
    [No Abstract]   [Full Text] [Related]  

  • 9. Manifestations of cerebral arteriosclerosis unaffected by a vasodilator.
    Practitioner; 1969 Nov; 203(217):695-8. PubMed ID: 4391604
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic correction of senile behavior characteristics with Wallerox. Contribution on experimental psychological geriatrics].
    Oswald WD; Müller-Egloff P; Becker E; Wilde M
    Munch Med Wochenschr; 1969 Jun; 111(26):1444-8. PubMed ID: 4980146
    [No Abstract]   [Full Text] [Related]  

  • 11. [The neuropeptide vasopressin in the recovery therapy of patients who have had viral hepatitis].
    Lobzin IuV; Volzhanin VM; Bakharev VD
    Voen Med Zh; 1985 Mar; (3):42-4. PubMed ID: 4002641
    [No Abstract]   [Full Text] [Related]  

  • 12. [The asthenic syndrome and mental work capacity].
    Shaposhnikov EA; Ioseliani KK; Chugunov VS; Narinskaia AL
    Aviakosm Ekolog Med; 1992; 26(3):59-65. PubMed ID: 1297495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of ribonucleic acid in cerebral atherosclerosis].
    Belonog RP; Mashek IuA
    Vrach Delo; 1974 Oct; 0(10):58-61. PubMed ID: 4417222
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of enerion in psychovegetative syndrome with pronounced asthenia].
    Veĭn AM; Fedotova AV; Gordeev SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(10):36-9. PubMed ID: 14628585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical efficacy of tanakan in patients with stage-I atherosclerotic circulatory encephalopathy].
    Rudenko AE; Lushchik UB; Dzhumik VA
    Lik Sprava; 1997; (2):99-101. PubMed ID: 9333499
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sturgeron treatment effectiveness in early cerebral arteriosclerosis].
    Belonog RP; Karaban' IN
    Vrach Delo; 1980 Sep; (9):67-9. PubMed ID: 7423956
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of Cinnarizine in cerebral arteriosclerosis. Improvement of the clinical picture as a result of increased oxygen supply and utilization due to Cinnarizine].
    Reimann-Hunziker R; Reimann-Hunziker GJ
    Praxis; 1969 Sep; 58(39):1239-42. PubMed ID: 4899503
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of cyclandelate on psychological test performance in patients with cerebral vascular insufficiency.
    Smith WL; Lowrey JB; Davis JA
    Curr Ther Res Clin Exp; 1968 Dec; 10(12):613-8. PubMed ID: 4972756
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vasobral in the treatment of initial atherosclerotic circulatory encephalopathy].
    Shprakh VV; Molokov DD; Tatarinova MB; Burdukovskaia NL
    Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(2):39-40. PubMed ID: 8754338
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of aminalon electrophoresis on brain bioelectrical activity in cerebral atherosclerosis patients with disordered cerebral blood circulation].
    Danilova IN; Neretin VIa; Nesterova LA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1980; (4):13-7. PubMed ID: 7415011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.